Combination with betalactamase inhibitor result in an antibiotic with increased spectrum of action with coverage against staphylococcus aureus, E coli Proteus, Klebsiella, salnonella, H, Influenzae, N, Gonorrhoea & Bacteroids fragilis .

Well Tolerated by patient with high safety profile.

Recommended as first line drug of choice.